Qing Zuraw

Qing Zuraw, MD, MPH, MBA, is a highly experienced professional in the field of clinical development, specializing in autoimmune diseases and rheumatology. Currently serving as Senior Vice President and Head of Global Clinical Development at RemeGen Biosciences, Qing Zuraw has previously held significant leadership roles at notable companies including The Janssen Pharmaceutical Companies of Johnson & Johnson, where Qing Zuraw was Group Head and Senior Director for Rheumatology & MFI Clinical Development, and Teva Pharmaceuticals as Senior Director of Respiratory Global Clinical Research & Development. Additional experience includes serving as Vice President of Clinical Development for Vadadustat at Akebia Therapeutics and as Senior Medical Director at Biogen.